Select a Region

North America

Newscenter

Browsing Archive: Rare DiseasesRare Diseases | EVERSANA

Posted on 8월 19, 20228/19/22

Case Study: Leveraging machine learning models in patient identification and behavior prediction for rare disease indications

Posted on 7월 27, 20227/27/22

EVERSANA’s Continued Commitment to Rare Disease

Posted on 5월 6, 20225/6/22

Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy

Posted on 4월 14, 20224/14/22

Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases

Posted on 4월 8, 20224/8/22

EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease

Posted on 3월 11, 20223/11/22

Gene Therapy in Today’s Digital World

Posted on 1월 26, 20221/26/22

Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem

Posted on 10월 14, 202110/14/21

Webinar: Discover Patient Support Program Needs for Patients with Rare Diseases

Posted on 10월 4, 202110/4/21

WEBINAR: Sustainability in Pharma: Access and Financial Returns

Posted on 10월 1, 202110/1/21

A Data-Driven Commercialization Pathway to Expedite Rare Disease Diagnosis and Adherence

Rare Diseases